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The establishment  of cell lines from mouse and human myelomas has  been 
attempted by a number of laboratories (1-6). Cultures of mouse myelomas have 
been  successfully  established  with  the  use  of feeder  cells  (2,  3)  and  with  the 
use  of a  phagocytic cell  factor (1).  Feeder  cells and proliferation  factors were 
found to be essential components for the proliferation of antibody-forming cells. 
Furthermore,  the  role of cell-to-cell  contact  has  been  implicated  in  culture 
initiation  and colony formation of lymphocytes (7-9). In spite of these results, 
the establishment  of a  long term culture of human multiple myeloma plasma- 
cytes has been relatively unsuccessful. 
Both the lymphocyte and the plasmacyte are vitally involved in the immune 
response.  Even though biochemically the proteins produced by both cell types 
are  identical,  there  are  several  unique  differences  between  the  morphological 
patterns  of lymphocytes (10,  11)  and plasmacytes (12,  13). 
We felt it important to establish  a human plasmacyte cell line to compare to 
normal lymphoid cell lines established  in our laboratory. This report describes 
the methods of cultivation,  morphology, and proliferative  characteristics  of a 
plasmacyte cell line derived from the tumor cells of a patient with IgD lambda 
multiple  myeloma. 
Materials and Methods 
Myeloma cells were obtained by removal of fluid from the right post thorax of a 59-yr old 
female with a 3 yr history of IgD myeloma. A light chain of the lambda  type was found in 
the serum, and a large amount of lambda-type Bence-Jones protein was detected in the urine. 
Skeletal lesions characteristic of multiple myeloma were also present. 
Initiation and Maintenance oJ Cultures.--Pleural fluid (1,500 ml) was collected in a sterile 
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flask containing 10,000 U of sodium heparin in 50 ml of Earle's balanced salt solution (EBSS) l 
without  Ca  ++ or  Mg  ++.  The heparinized pleural fluid,  containing 1,400  white blood cells 
(WBC)/m  3,  was  divided  into  250-ml  samples  and  centrifuged at  1,500  rpm  for  10  rain. 
The fluid was removed from the tubes by aspiration, and the cell pellets were washed twice 
with EBSS (Ca  ++ and Mg  ++ free). 
The pellets were resuspended in various media to a concentration of 7 X  106/ml, and half 
of each cell suspension was inoculated  into 250-ml Falcon flasks  (Falcon Plastics,  Div.  of 
BioQuest, Oxnard, Calif.). The remaining half of each suspension was inoculated into similar 
flasks containing an agar substrate overlay described below. All of the flasks were incubated 
in an atmosphere of 5% CO~ and 95% air at 37°C. 
The cultures were fed twice weekly by standing the flasks on end in the incubator to allow 
the cells to settle. One-half of the medium from each flask was removed by aspiration and 
replaced with fresh medium to the original volume. 
Preparation  of Agar Substrate Overlay.--The bottom of each flask was covered with 7 ml of 
an agar solution containing one part 3% agarose in three times distilled pyrogen-free water 
(sterilized by autoclaving); one part EBSS without Ca  ++ or Mg++; and one part fetal calf 
serum (FCS) which was heat inactivated at 56°C for 30 min. The agar was dissolved by boiling 
and allowed to cool in a 56°C water bath before the other ingredients were added. The liquid 
agar solution was spread over the bottom of each flask and the flasks were left at room tem- 
perature until the agar solidified.  The flasks were stored upside down at 4°C. The media and 
cells were added to the flask directly onto the agar surface. 
Nutritional  Media.--RPMI  1640  (Grand  Island  Biological  Co.,  Grand  Island,  N.  Y.), 
Eagle's MEM, and Dulbecco's modified media were used in separate attempts to initiate cell 
growth. These media were supplemented with either FCS or human AB (HAB) serum (heat 
inactivated for 30 min. at 56°C),  I% glutamine, and 1% fungizone and penstrep (GIBCO). 
Cultures were kept at a pH of 6.6-6.8 by adjusting with sterile HC1 or NaOH. 
Cell viability remained low after 1 mo of cultivation. Therefore the ceils were spun down 
and resuspended in special RPMI 1640  base medium  MJLA-1  (Table 1)  and supplemented 
with the following: 50 #g  of  gentamicin reagent  (Microbiological Associates, Inc., Los An- 
geles,  Calif.), 1% fungizone, and 40% FCS (Reheis Chemical Co., Chicago, 111.).  2 Cells were 
resuspended in the new medium to half the original volume and returned to the same flasks. 
Preparation  of Fibroblast "Feeder Cells" and Fibroblast Conditional Medium (FCM).--Fibro- 
blasts that grew out in the original culture were replaced by cultured irradiated human normal 
skin fibroblasts. Normal fibroblasts obtained from two donors were separately cultured until 
monolayers formed. Each culture was trypsinized and resuspended in medium to a concentra- 
tion of 106/ml. 7 ml from each cell suspension were added to separate 250-ml flasks (14,  15) 
before irradiation with 2,000 fads of cobalt-60. The irradiated cells were incubated overnight 
at 37°C in an atmosphere of 5% C02 and 95% air. Myeloma cells were added to the flasks after 
incubation. 
FCM was obtained from a monolayer culture of normal human skin fibroblasts. FCM was 
removed from the culture ceils on the 3rd day after feeding. The medium was spun for 10 min 
at 1,500 rpm and filtered through a 0.45/zm Nalgene filter (Nalge Co., Naigene Labware Div., 
Rochester, N. Y.). 
The activity of  the stimulating factor contained in the FCM  was determined  by serial 
dilutions of the media. 1 ml of the dilutions was added to 1 ml of the MJLA-1 medium contain- 
1 Abbreviations  used in this paper:  EBSS,  Earle's balanced salt solution; FCM, fibroblast 
conditional medium;  FCS,  fetal calf  serum;  HAB,  human  AB  serum;  PSF,  plasmacyte- 
stimulating factor; WBC, white blood cells. 
12 lots of FCS from various companies were tested on these cells, and Reheis was found 
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TABLE  I 
Media MJLA-I 
Media ingredients  nag/liter  Media ingredients  mg/liter 
L-arginine  305.0 
L-cystine (di HC1)  81.0 
T.-hisfidine  46.0 
L-isoleucine  70.5 
L-leucine  102.5 
Biotin  0.20 
Vitamin B12  0.005 
Calcium pantolhenate  0.25 
Choline chloride  3.0 
Folic acid  1.0 
i-inosital  35.0 
Nicotinamide  1.0 
Para amino benzoic acid  1.0 
Pyridoxine HC1  1.0 
Rivoflavin  0.20 
Thiamine HC1  1.0 
Glutathionine reduced  1.0 
Dextrose  2,000.0 
NaCI  6,000.0 
Potassium Ci  400.0 
NaHCO3  2,200.0 
Na2HPO4  1,512.0 
MgSO47H20  100.0 
Ca(NO3)24H20  100.0 
Phenol red  5.0 
L-lysine  98.0 
L-methionine  30.0 
L-phenylalanine  47.0 
L-threonine  68.0 
L-tryptophane  15.0 
L-tyrosine (Na)  25.7 
L-valine  66.0 
L-glutamine  884.0 
L-alanine  1.78 
L-aspartic acid  46.6 
L-asparagine  80.0 
L-glutamic acid  49.4 
L-proline  43.0 
L-serine  51.0 
Glycine  25.0 
ng 1 X  105 viable myeloma cells. The cells were incubated at 37°C  (5% CO2 95% air) in  15- 
ml culture tubes standing upright. The viabilities and cell counts were read daily for 10 days 
on a cytograf (Bio/Physics Systems Inc., Mahopac, N. Y.) in the presence of trypan blue. The 
titer of  the stimulating factor was expressed as  the highest dilution which yields  maximal 
growth over a  10-day period. During this period the cells were fed twice weekly by removing 
half the volume and replacing it with fresh media. 
Conditioned media of different kinds were also obtained from five established lymphoid 
cell lines, two macrophage cell lines, and one thymus epithelial cell line, all of which were de- 
rived from normal human tissue. The growth-stimulating activity of each of these media was 
assayed by adding 1 ml of conditioned media to 1 ml of myeloma cell suspension containing 
1.5  X  105 vaiable cells/ml. These cells were incubated as above for 3 days. The viability and 
cell counts were recorded as before. 
Isolation  and Identification  of Plasmacyte-Stimulating  Factor (PSF).--Isolation of PSF was 
carried out by first concentrating FCM ten times with a  Diaflow Ultrafilter (Amicon Corp., 
Lexington, Mass.) containing a PM10 membrane. The concentrated medium was fractionated 
on Sephadex G-100 and G-200 columns (Pharmacia Fine Chemicals, Inc., Piscataway, N. J.) 
equilibriated with 1.5% Tris-NaCl buffer at pH 8.6. The columns were calibrated with oval- 
bumin, bovine albumin, and aldolase before the media was fractionated. Conditioned media 
from lymphoid cell lines and fresh media were used as controls. After the optical density of 
each fraction was determined, the fractions were sterilized by filtering through a  .22 micron 
millipore filter. The sterile fractions were added to 1 X  105 viable myeloma plasmacytes con- 
taining 1 ml of MJLA-1 media (pH 7) (Table I). The cells were incubated for 48 h  at 37°C  in 
5% CO2 and 95% air. Cell counts and viability were recorded every 12 hr. The  population 
distribution, cell size changes, cell counts, and viability of this assay were measured on a  cyto- 
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Heat inactivation was carried out on Fraction no. 20 of the FCM collected from the Sepha- 
dex G-200 column. The fraction was divided into six portions and heat inactivated for 30 min 
at the following temperatures: 30  °, 40  °, 50  °, 60  °, 70  °, and 80°C. Trypsin digestion was per- 
formed on Fraction no. 20 containing 200/~g/ml trypsin and incubated for 3 h at 37°C. The 
reaction was stopped by adding 500/zg/ml soybean trypsin inhibitor. The heat-inactivated and 
trypsin-digested fractions were sterilized as above and assayed back on 1 X  105 plasmacytes/ 
ml. Cell counts and viability were performed after 72 hours and the percent increase over the 
original cell count was recorded. 
Chromosome Studies.--The effects of fibroblasts  or FCM  on myeloma plasmacytes  were 
studied on cells that were grown fibroblast-free or FCM-free for 2 wk. The mitotic coefficient 
was calculated before and 24 h after the myeloma cells were added to new fibroblasts. The cells 
were then fixed with 1:3 acetic acid and alcohol, and flame dried to spread the chromosomes 
(16,  17). The chromosome spreads  were stained  for 5 min in  10%  Giemsa stain  and  90% 
buffered HeO. The slides were surveyed under oil emersion; 1,000 cells were counted on each 
slide and the number of ceils in metaphase recorded. The cells in metaphase were also examined 
for abnormal karyotypes. 
Identification of Immunoglobulin Synthesized by the Myeloma Cells in Tissue Culture.--The 
culture  fluid was collected and  analyzed  with immunoelectrophoresis and  the Ouchterlony 
method, and compared with the patient's serum and pleural fluid using specific anfisera against 
IgG, IgA, lgM, and IgD and kappa and lambda chains (Meloy Laboratories Inc.,  Springfield, 
Va.). Further analysis of the cultured cells was made by [3H]leucine incorporation studies. 
Electron Mieroscopy.--Cells  for transmition electron microscopy were pelleted by centrifu- 
gation at 1,500 rpm for 10 rain and fixed in 3% glutaraldehyde in cacodylate buffer. The pellets 
were dehydrated  in ethanol and  embedded in epoxy (Spurr),  then osmicated and post fixed 
with urinal acetate and lead. 
Cells for  scanning  electron microscopy were cultured  on  25-mm  diameter  cover glasses 
placed in 35 X  10 Falcon patti dishes.  Irradiated fibroblasts were added to the petri dishes and 
allowed to attach to the cover glasses.  Myeloma cells were then added and the cultures were 
incubated for 2 days. The cells on the cover glasses were fixed in glutaraldehyde, osmicated, 
and dehydrated with ethanol in situ. A cover glass bearing the ethanol-saturated cells was in- 
serted in a special cover glass holder and dried in COs by the critical point method (18).  The 
dry monolayer was coated with successive layers of carbon and gold. 
RESULTS 
Initiation of a Continuous Culture.--The myeloma plasmacytes were cultured 
for 1 mo in Eagle's MEM,  RPMI  1640,  and Dulbecco's medium  (Table II). As 
can  be  concluded  from  Table  II,  establishment  of  a  continuous  culture  of 
myeloma plasmacytes  was possible only in  the presence  of fibroblasts  overlaid 
with  agar.  The myeloma cells formed  colonies in  the  agar over the  fibroblasts 
approximately  1 mo after the initiation of the cultures.  By the 2nd mo of culti- 
vation, the agar had been digested and the myeloma cells had formed aggregates 
attached  to  the fibroblasts. 
The  media  used  initially  (Table  II)  supplemented  with  heat-inactivated 
FCS, however, were not ideal. Viability and cell counts remained low. The addi- 
tion of large amounts of amino acids (media MJLA-1,  Table  I)  increased  both 
viability  and  cell  count.  Under  these  conditions,  viable  cell  counts  eventu- 
ally increased  to 80-90%  at 3.5  X  106. 
By the 4th  too,  the fibroblasts  began  to decrease in viability and  cell count. 498  ESTABLISHMENT  OF A  HUMAN  PLASMACYTE CELL LINE 
TABLE II 
Initiation of Plasmacyte Cell Line LA no. 49 
Initiation media  % Viable  1 mo  % Viable  16 days after 
late  addition of MJLA-1 
1.  RPMI 1640 +  FCS4o  0  0 
2.  RPMI 1640 +  FCS4o +  agar  15  58 
3.  RPMI 1640 +  HAB4o  3  2 
4.  RPMI 1640 +  HAB4o +  agar  12  50 
5.  Dulbeccos +  FCS4o  0  0 
6.  Dulbeccos  +  FCS4o +  agar  10  50 
7.  Dulbeccos +  HAB4o  0  0 
8.  Dulbeccos +  HAB4o +  agar  7  12 
9.  MEM +  FCS2o  0  0 
10.  MEM +  FCS2o +  agar  0  0 
The above media were supplemented with either 40% FCS or 40% HAB sera. Fibroblasts 
grew out in culture numbers 2, 4, 6, and 8. MEM supplemented with FCS and agar overlay 
was still not rich enough in amino acids to support growth of the plasmacytes. 
The myeloma plasmacytes were removed from the nonviable fibroblast culture 
and added to freshly irradiated fibroblasts. Since the fibroblasts were irradiated 
in order to control overgrowth, the concentration of FCS was dropped to 20 %. 
Cell count and viability again increased in the presence of irradiated fibroblasts. 
The miotic coefficient  of the plasmacytes was less than  1% after the death of 
the fibroblasts. After transferral of plasmacytes to new fibroblasts they began 
to proliferate almost synchronously, reaching a  miotic coefficient  of 36.4%  in 
metaphase by 24 h. The myeloma plasmacytes continued to proliferate for 2 mo 
until the death of the fibroblasts. 
Immunoglobulin  Characterization.--The pattern of immunoglobulin synthesis 
by the cells maintained in culture was the same as that from the original tumor 
as shown by immunoelectrophoresis and Ouchterlony comparison (Fig. 1) with 
specific  antisera.  Biosynthetic  study  of  the  established  cell  line  LA-49 with 
[14C]leucine demonstrated synthesis and secretion of IgD myeloma protein. The 
myeloma plasmacytes still secreted the myeloma protein  IgD lambda 1 yr after 
cultivation.  The media,  concentrated  three  times,  produced a  visible  line  of 
precipitation  when  tested  against  specific  anti-IgD  sera  by the  Ouchterlony 
technique. 
Light  and  Electron  Microscopy  of Cultured  Myeloma Cells--Examination  of 
myeloma plasmacytes from patient  and  culture by light microscopy revealed 
no morphological differences  between cells from the two sources (Fig. 2). Both 
original and cultured myeloma cells were similar in size, ranging from 15 to 20 
/zm. They were multinucleated and polyploid, with chromosome counts varying 
from 23  to over 250  (Fig.  3).  Most of the  cells  contained  one  or more  large 
hyaline bodies. Plasma cells in all stages of maturation, from immature blasts 
to mature plasmacytes, were found in the cultured cells. M.  E.  JOBIN,  J.  L.  FAHEY,  AND  Z.  PRICE  499 
FIo.  1. Demonstration of D lambda myeloma protein from LA-49 culture fluid. A, SE 
pleural fluid (with D myeloma protein); B, LA-49  culture fluid (at 9 mo); C, LA-85 culture 
fluid (IgG- and IgM-producing  llne); D, specific  antisera for IgD; and E, specific  antisera for 
lambda light chains. 
The cultured myeloma cells were obviously of plasma cell origin. They were 
easily distinguished from other cells of the lymphoid series by their large round 
nucleus  and  basophilic  cytoplasm containing  a  well  developed ergastoplasm 
(Figs. 2 and 4). 
Scanning electron microscopy of myeloma cells cultured with fibroblasts re- 
veals a spherical rough-surfaced cell attached to the smooth-surfaced fibroblast 
(Fig. 5). The fibroblast played host to one or more plasmacytes. The irregulari- 
ties on the surface of the plasmacytes probably represent protrusions of vesicles, 
convolutions of the cell membrane, and microvilli. Cell membrane irregularities 
of this kind can be seen in thin sections of myeloma cells (Fig. 4). 
The mechanism by which the myeloma cells are attached to the fibroblast is 
unknown.  The attachment is not secure because clumps of plasmacytes often 
break free of the fibroblast and resuspend in the medium. Entanglement of sur- 
face irregularities of the myeloma cells with microvilli of the fibroblast may be 
the mechanism of attachment. 
The micro morphology of the cultured plasmacytes as seen in thin sections Fit.  2.  (A) Plasmablasts containing cytoplasmic vacuoles (Mott cells) isolated from the 
pleural  fluid  upon  initiation of  culture.  (B)  Plasmablasts 9  mo after initiation of  culture. 
Intranuclear inclusions, multinucleation, and  Mort vaculation were characteristic of  these 
cells throughout the course of cultivation. 
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FIo.  3.  Metaphase  chromosome pattern of cultured cells.  This plate contained extremely 
high number of chromosomes, approximately  250. 
was typically that of the plasma cell: an eccentric nucleus with clumped granu- 
lar chromatin and cytoplasm filled with parallel arrays of granular endoplasmic 
reticulum.  Most  of  the  cultured  myeloma cells  contained  many large  mito- 
chondria and a few of the cells contained numbers of lipid bodies (Fig. 4), a not 
unusual finding for cultured cells. 
Substitution of Fibroblasts with FCM Containing a Stimulating Factor.--It was 
observed  that  the  media  taken  from a  normal  fibroblast  cell  line  could  also 
stimulate  the  myeloma plasmacytes.  Fig.  6  represents  growth  curves  of  the 
plasmacytes with irradiated fibroblasts, or FCM, as compared to controls con- 
taining  only media.  In the presence of fibroblasts,  the  myeloma plasmacytes 
reached a maximal cell count of 3  X  l0 s. In the presence of FCM the myeloma 
cells reached a  maximum of 6  X  105 viable cell count,  while the cell controls 
without either eventually had total cell death. Attempts to concentrate the cells 
in  the  controls  in  order  to  reach  a  higher  viable  count  still  failed  to  induce 
proliferation of the culture. 
The mitotic coefficient 24 h  after the addition of FCM was the same as that 
of the  cultures  containing  fibroblasts.  The  highest  dilution  of the  FCM  that 502  ESTABLISHMENT  0]~  A  HUMAN PLASMACYTE CELL  LINE 
FIO. 4.  A section of cultured plasmacytes in various stages of maturation. A blast stage 
is at the lower right, a mature plasmacyte is at top right, and an older degenerating plasma- 
cyte is at the left. The eccentric nucleus with marginated clumps of chromatin and parallel 
rough endoplasmic reticulum are characteristic of the plasma cell.  Numbers of lipid bodies 
and myelanted mitochondrial membranes in the cell on the left are suggestive of degenerative 
processes. X  12,000. 
could stimulate cell growth was found to be  1:1024.  The  greatest stimulation 
was produced when  the factor was diluted from 1 : 2  to 1 : 16. 
Conditioned media from the other cell types had no effect upon  the growth 
or the mitotic coefficient of the plasmacytes. In fact, almost total cell death of M.  E.  JOBIN~  J.  L.  FAHEY~  AND  Z.  PRICE  503 
FIG. 5.  Scanning electron microscopy of plasmacyte attached  to a fibroblast. The irregu- 
larities on the surface of the plasmacyte are microvilli (arrows) and protruding vesicles (Fig. 
4). The surface of the fibroblast is relatively smooth with scattered short and long microvilli. 
The points of contact between plasmacyte and fibroblast are indistinct. 10,000, 10 kV, 60  ° tilt. 
the plasmacytes occurred 3  days after conditioned media from other cells was 
added. It was also noted that the lymphoid cell lines derived from normal donors 
not only failed to establish in the presence of fibroblasts, but also the addition 
of FCM resulted in decreased viability of the lymphoid cells. 
Characteristics of the Stimulating  Factor--Fractions  containing plasmacyte- 504  ESTABLISHMENT  OF  A  HUMAN  PLASMACYTE  CELL  LINE 
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FIG.  6.  Growth curves of cultured cells containing fibroblasts (--).  Cultures containing 
1 : 16 dilution of FCM (---). Cultures containing media only (--.--).  Doubling time in cultures 
containing fibroblast was every 21-24 h. All cultures containing media only eventually had 
total cell death. Cultures containing a 1  : 16 dilution of the FCM could continue to proliferate 
provided they were fed every 3 days with media containing the factor. 
stimulating factor (PSF)  were found in  tubes 13-17  from the Sephadex G-100 
column,  and  in  tubes  18-22  from  the  Sephadex  G-200 column  (Fig.  7).  The 
fractions containing bovine albumin from FCS were found to prolong life of the 
myeloma plasmacytes for 6 days; however, there was no increase in the viable 
cell  count during  this period.  The fractions containing  amino acids kept 10% 
of  the  cells viable for 3  days,  while  the  contents  of  the  remaining  fractions 
neither stimulated proliferation nor promoted life. The fractions containing the 
factor showed a fourfold increase of viable cells during a period of 6 days. 
The mol wt of the factor was estimated to be about 150,000  daltons by com- 
parison with the G-200 distribution of proteins of known size. Further purifica- 
tion and characterization of the stimulating factor is in progress. 
The factor was found to be heat labile and sensitive to trypsin. The cell counts 
failed to raise and, in fact, decreased from 1 X  105 to 8 )< 104 72 h after the addi- 
tion of the trypsin-digested PSF. The factor was stable for 3 days at  37°C and 
for more than 1 yr at -70°C. 
DISCUSSION 
The results indicated  that successful initiation  of a  human neoplastic plas- 
macyte line was dependent upon three factors: (a)  the ability of the myeloma 
cells to form colonies in an agar overlay (7,  8) ; (b)  the presence of fibroblastic 
cells; and (c) high concentrations of amino acids in the culture medium. Similar 
results have been reported for a  murine plasmacytoma using culture  medium 
of tissue macrophages or spleen phagocytic cells (1),  and by the use of fibro- 
blastic feeder layers (2,  19). M.  E.  JOBIN,  J.  L.  FAHEY,  AND  Z.  PRICE  505 
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FIG.  7.  G-200 chromatography  of  partially  purified  media.  Conditioned  media  from  a 
hematopoetic cell  line LA-102  (control)  and  fibroblast cell  line  (Riceo)  was  concentrated 
10-fold and fractionated on a Sephadex G-100 column equilibrated with 1.5% Tris-NaC1 buffer 
at pH 8.6.  Tubes containing protein of 100-200,000 daltons were pooled and refractionated 
on a  Sephadex G-200 column. The above figures represent the protein peaks at 280 OD  of 
fractions 12-34. The PSF was found in tubes 18-22 of the fibroblast culture medium (Ricco), 
but not in comparable fractions of LA-102 medium. 
A PSF from a conditioned media, or the presence of irradiated fibroblast, was 
found to be essential for the maintenance and further proliferation of this es- 
tablished cell  line. The myeloma cells proliferated for 2 mo until  the death of 
fibroblasts, and for 3 days in the presence of fresh FCM. The experimental re- 
sults presented in this report indicate that proliferation depends upon a factor 
produced by normal human fibroblasts. The PSF was not required for continu- 
ous lymphoid cell lines. Indeed, it appeared that it might be toxic for some cells. 
Production  of PSF  was characteristic of fibroblasts. All four fibroblast cell 
lines tested produced the factor. The capacity can be lost with extended culture 
of the fibroblast lines. In contrast to the fibroblast, lymphoid cell lines (five) and 
epithelioid cultures (two) failed to produce the factor. 
The factor itself was found to be a heat labile protein with a mol wt of 150,000. 
It was stable for 3 days at 37°C and for more than 1 yr at -  70°C. 
The ultrastructure of LA-49 revealed a large quantity of endoplasmic reticu- 
lum in  comparison  to  that  seen in  cultured  lymphoblasts. The mitochondria 
were large and situated  between ergastoplasmic sacs studded  with  ribosomes. 
Electron  microscopy of the  cell  line  revealed  that  cultured  cells  continue  to 
mature from plasmablasts to mature plasmacytes in vitro, a characteristic not 
present in lymphoid cell lines (20). Light microscopy revealed large Mort bodies 
and  nuclear  inclusions  typical  of  a  myeloma  plasmacyte.  These  abnormal 506  ESTABLISHMENT OF  A HUMAN PLASMACYTE CELL LINE 
morphological characteristics of the neoplastic myeloma cell remained after the 
cell line became established in culture. 
The criteria for determining whether a human cell line is derived from normal 
or malignant  cells has been outlined  by Belpomme et al.  (19).  These criteria 
suggest  that  LA-49  was  derived  from  the  neoplastic  cell.  The  karyotype of 
LA-49 revealed polyploidy with no common multiple of a chromosome number, 
while  lymphoid  cell  lines  established  in  our  laboratory  are  either  diploid  or 
pseudodiploid. LA-49 not only formed colonies in soft agar, but produced the 
myeloma protein IgD lambda. The myeloma protein from LA-49 was identical 
to that synthesized by the patient's tumor. 
Since this was the first time in our laboratory that we were able to study the 
proliferative, maturational, and functional characteristics of a human plasma- 
cyte cell line, it is essential that additional attempts be made to culture other 
myeloma cell lines in order to expand upon the results stated here. Further char- 
acterization of this cell line and its role in immunological disease is in progress. 
It is possible that the location (and the attendant  destructive lesions)  may 
depend  upon  the local production of a  growth-supporting factor such  as  that 
described here. The concept of normal cell (product)  and malignant cell  inter- 
relation  as  a  necessary condition  of tumor  growth  deserves  consideration  in 
multiple myeloma. 
SUMMARY 
Cell line LA-49, derived from pleural fluid cells of a patient with IgD multiple 
myeloma, was established in culture and maintained for more than  1 yr. The 
D-myeloma protein produced in culture was similar to the serum D-myeloma 
protein in electrophoretic mobility and in delta- and lambda-chain antigens. 
The plasma cell tumor culture, LA-49, differed from numerous immunoglobu- 
lin-producing B-lymphoblastoid cell lines established in this laboratory in: (a) 
Morphology  (revealing  various  stages  of  maturation);  (b)  type  of  immuno- 
globulin produced (IgD vs. IgM, IgG, and/or, rarely, IgA); (c) growth charac- 
teristics (requirement of plasmacyte-stimulating factor) ; and (d)  chromosomal 
features (polyploid vs. pseudodiploid). 
A growth factor was needed for cell division and maintenance of culture via- 
bility. This factor was supplied  readily by irradiated  feeder layers of normal 
human  fibroblasts or conditional  media from fibroblast  cultures.  Preliminary 
characterization of this factor revealed it to be a protein with a tool wt of ap- 
proximately 150,000  daltons. 
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